Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 29, 2021

BUY
$2.09 - $3.09 $7,701 - $11,386
3,685 New
3,685 $9,000
Q2 2020

Aug 07, 2020

SELL
$2.2 - $3.71 $8,107 - $13,671
-3,685 Closed
0 $0
Q1 2020

May 05, 2020

BUY
$1.9 - $4.98 $7,001 - $18,351
3,685 New
3,685 $9,000

Others Institutions Holding TCRT

About Alaunos Therapeutics, Inc.


  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $443M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Key F Inancial Inc Portfolio

Follow Key F Inancial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Key F Inancial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Key F Inancial Inc with notifications on news.